Product Information

XOFLUZA 80 MG TABLET is a brand product labeled by Genentech, Inc., priced at $161.9683 per EA under NDC 50242087701. Its NADAC has been published 244 times since Dec 22, 2021.

FDA first approved this application on Oct 24, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

XOFLUZA 80 MG TABLET

BALOXAVIR MARBOXIL
$161.9683per EA

Strength

80 mg/1

Manufacturer

Genentech, Inc.

NDC

50242087701

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

BALOXAVIR MARBOXIL

Approval Type

New Drug (NDA)

FDA Application

NDA210854

FDA Approved

10/24/2018

TE Code

AB

On Market Since

10/24/2018

Pharmacological Classes

Chelating Activity
Polymerase Acidic Endonuclease Inhibitor
Polymerase Acidic Endonuclease Inhibitors

Price Statistics

The NADAC for XOFLUZA 80 MG TABLET has been published 244 times since Dec 22, 2021, and over the history we have for it it has risen 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$161.9683 per EA
All-time high$163.2527 (Jan 14, 2026)
All-time low$144.0311 (Dec 22, 2021)
52-week high$163.2527
52-week low$161.9572
Median price$152.4942
Average price$153.6525
Largest weekly change+3.0% (Jul 12, 2023)
Weeks tracked244
Tracking sinceDec 22, 2021

Price History

1W

0.0%

1M

0.0%

3M

-0.0%

6M

-0.2%

1Y

-0.1%

3Y

+7.7%

5Y

N/A

All

+12.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BALOXAVIR MARBOXIL market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of XOFLUZA 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for XOFLUZA 80 MG TABLET, manufactured by Genentech, Inc., is $161.9683 per EA (NDC 50242087701), effective Aug 19, 2026.

How has the price of XOFLUZA 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for XOFLUZA 80 MG TABLET has risen 12.5%. It has been tracked across 244 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for XOFLUZA 80 MG TABLET?

Since Dec 22, 2021, the NADAC for XOFLUZA 80 MG TABLET has ranged from a low of $144.0311 (Dec 22, 2021) to a high of $163.2527 (Jan 14, 2026), with a median of $152.4942 per EA.

Are there cheaper alternatives to XOFLUZA 80 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of XOFLUZA 80 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures XOFLUZA 80 MG TABLET?

XOFLUZA 80 MG TABLET (NDC 50242087701) is labeled by Genentech, Inc., and CMS classifies it as a brand product.